UBS Assumes Myriad Genetics (MYGN) at Neutral
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $4.01 +3.08%
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
UBS analyst Douglas Schenkel assumes coverage on Myriad Genetics (NASDAQ: MYGN) with a Neutral rating and a price target of $3.60.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $3.18 yesterday.
You May Also Be Interested In
- Jefferies Starts United Overseas Bank Ltd. (UOB:SP) (UOVEY) at Buy
- Motilal Oswal Securities Starts Pine Labs (PINELABS:IN) at Buy
- Nomura/Instinet Starts Chow Tai Seng Jewellery Co Ltd (002867:CH) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
